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The feasibility of endovascular aortic repair
strategy in treating infected aortic aneurysms
Chung-Dann Kan, MD, PhD,a Hsu-Ting Yen, MD,b Chung-Ben Kan, MD,c and
Yu-Jen Yang, MD, PhD,a Tainan, Kaohsiung, and Chia-Yi, Taiwan
Background: Open surgical treatment for an infected aortic aneurysm has a high rate of surgical morbidity and mortality
and does not guarantee eradication of the infected nidus. The use of endovascular aortic repair (EVAR) might simplify
the procedure and provide a good alternative for this critical condition, but this remains to be proved. This study assessed
the efficacy and outcome of EVAR with an adjunctive antibiotic treatment strategy.
Methods: We focused on the experiences and results of the management of infected aortic aneurysms with positive blood
cultures. We drew the blood for culture study, immediately prescribed broad-spectrum antibiotics, performed EVAR
procedures, and followed this with sensitive antibiotics and adjunctive procedures.
Results: Twelve consecutive patients (mean age, 70 years) were included in this EVAR strategy. Three patients had
thoracic, two thoracoabdominal, and the remaining seven had infected abdominal aneurysms. Ten Salmonella, one
Staphylococcus, and one Streptococcus spp were identified. There was no hospital death. Three patients underwent computed
tomography (CT)-guided drainage, and one underwent open laparotomy debridement. Mean follow-up was 24 months.
One late death occurred but was unrelated to reinfection. All patients seemed well, with no evidence of EVAR graft
infection at a mean follow-up of 23.6 months.
Conclusions: This small multi-institutional study summarizing the experiences of patients with an infected aortic
aneurysm managed by EVAR and an aggressive antibiotic strategy revealed that this EVAR strategy might be a suitable
approach to treating this disease. These favorable results may be typical for Salmonella infection, which was present in
most of the patients. Further experience is needed to assess whether this therapeutic strategy works equally well in
aneurysm infection caused by other organisms. (J Vasc Surg 2012;55:55-60.)
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mInfected aneurysms represent a highly lethal but small
minority of aortic diseases.1,2 Management remains a clin-
ical challenge for vascular surgeons. The major causes of
death were reported to be advanced age, non-Salmonella
infection, and lack of surgical intervention.3 Traditionally,
aggressive surgical resection, debridement of infected peri-
aortic tissues, and reconstruction of the aortic flow by
anatomic or extra-anatomic techniques, are the gold stan-
dard treatment choice for these critical situations.4,5 How-
ever, this surgical strategy continues to possess a high
possibility of morbidity and death.4,6,7
Endovascular aortic repairs (EVAR) for thoracic and
abdominal aortic aneurysms have become widely accepted
in the last 2 decades.8,9 However, questions have been
raised about the clinical application of EVAR in the setting
of an infected aortic aneurysm. After Semba et al10 reported
the successful use of EVAR to treat infected aortic aneu-
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doi:10.1016/j.jvs.2011.07.077ysms, several investigators also used the technique with
cceptable results.11,12 We reviewed and analyzed the out-
ome of 48 reported infected aortic aneurysms treated by
VAR13 and found that ruptured aneurysm and fever at
peration are the two most significant predictors for per-
isting infection and that persistent infection is bad for the
verall prognosis.
Our meta-analysis also showed that EVAR may yield
cceptable clinical results and might be a possible alterna-
ive strategy in managing infected aortic aneurysms. We
hus compared and analyzed the surgical results of infected
bdominal aortic aneurysms treated by conventional sur-
ery and EVAR procedures in our institute and those from
eviewed reported cases.2 This study revealed that the
ignificant predictors for aneurysm-related morbidity and
eath were age, Salmonella spp infection, leukocytosis, and
ossibly aortoenteric fistula and shock, but not the EVAR
r conventional surgical procedure per se.
The results convinced us that EVAR might be an
lternative approach for treating this disease, and since
007, we have prospectively treated these patients exclu-
ively using EVAR procedures in three tertiary hospitals in
outhern Taiwan. The infected aneurysms in this series
ost likely were caused by infectious aortitis rather than
nfection of pre-existing aneurysms. We report our experi-
nces and results.
ATERIAL AND METHODS
The diagnosis of infected aortic aneurysm was deter-
ined by the clinical course, aortic image, and positive
esults from blood cultures. To focus on the experiences
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excluded patients whose blood culture data were negative,
although from previous reports these patients might ac-
count for up to 27% of infected aortic aneurysms.13 The
following protocol was used:
● draw blood for culture study before antibiotic use in
every possible infected aortic aneurysm case encoun-
tered,
● immediately prescribe broad-spectrum antibiotics,
● electively perform EVAR procedures if the patient’s
vital signs are stable and fever status are controlled, and
urgently or emergently perform EVAR procedures if
the patient’s hemodynamic status is unstable or resus-
citated,
● follow-up with computed tomography (CT) angiog-
raphy within 1 week after the procedure,
● proceed with CT-guided percutaneous drainage or
minimal surgical debridement if necessary, and
● administer bacteria specific-sensitive intravenous anti-
Table I. Demographic data, medical comorbidities, and fi
Pt Sex Age Location Comorbidities
Fever at
admit
P
tre
(
1 M 83 AA HTN, ESRD N
2 M 65 AA HTN, DM Y
3 M 61 TAA HTN, DM Y
4 F 78 AA HTN, DM Y
5 M 76 AA HTN Y
6 F 81 TAA HTN, CAD, CKD N
7 M 57 AA HTN Y
8 M 81 AA HTN, CAD, AF, COPD N
9 F 68 TA DM, CAD, CHF, DU Y
10 F 66 TA None N
11 M 75 A HIVD Y
12 M 49 TAA HTN Y
AA, Abdominal aorta; AF, atrial fibrillation; CAD, coronary arterial disease
chronic obstructive pulmonary disease; DA, dissecting aneurysm; DM, diab
renal disease; HIVD, herniated intervertebral disc; HTN, hypertension; PSA
Table II. Pathogens and patient outcomes
Pt
Cultured
pathogen
Max AA
size (mm)
Adjunctive
procedures
1 Salmonella 6.3 . . .
2 Salmonella 2.8 . . .
3 Salmonella 3.3 . . .
4 Salmonella 2.5 . . .
5 Salmonella 5.7 . . .
6 Salmonella 4.9 . . .
7 Salmonella 3.3 PCD
8 Salmonella 8.2 PCD/open draina
9 Staphylococcus 4.1 . . .
10 Salmonella 6.1 . . .
11 Salmonella 4.8 PCD
12 Streptococcus 4.8 EVVB
AA, Aortic aneurysm; ARF, acute renal failure; ESRD, end-stage renal disebiotics for at least 4 weeks postoperatively. iClinical details, including age, sex, clinical presenta-
ion, symptoms, culture results, details of treatment, mor-
idity, and mortality, were collected for analysis. Data
ollection was approved by the Institutional Review Board
f the National Cheng-Kung University Hospital.
ESULTS
Between January 2007 and April 2011, 12 consecutive
atients (eight men, four women) with infected aneurysms
f the thoracic or abdominal aorta, or both, were treated
sing this EVAR strategy. Patients were a mean age of 70
ears (range, 49-83 years). The demographic data and the
athogens are presented in Tables I and II.
Three patients had infected thoracic aneurysms, two
atients had infected thoracoabdominal aneurysms, and
he remaining seven had infected abdominal aneurysms.
ypertension was present in nine of 12 patients (75%),
iabetes mellitus in four (33.3%), coronary arterial disease
gs
t Pre-op
fever Specific findings
N PSA
N PSA, aortic wall gas
N PSA
N PSA/DA, contained rupture
Y PSA, intractable abdominal pain
N PSA, ruptured, bloody sputum
N PSA, psoas abscess
N PSA, contained rupture, psoas abscess, osteomyelitis
Y PSA, ruptured
N PA, contained ruptured
Y PA, ruptured, syncope, psoas abscess
N PA/DA
F, congestive heart failure (New York Heart Association class IV); COPD,
ellitus; DU, duodenal ulceration; E, emergent operation; ESRD, end-stage
doaneurysm; TA, thoracic aorta; TAA, thoracoabdominal aorta.
Complication
Follow-up
(months)
Late
survival
None 48 Yes
None 41 Yes
None 40 Yes
None 40 Yes
None 36 Yes
ARF 25 Yes
None 20 Yes
Persistent fever,
osteomyelitis
13 Yes
Prolonged ventilation, ARF 8 No
None 6 Yes
None 4 Yes
ESRD 2 Yes
VB, extra-anatomic visceral vessels bypass; PCD, percutaneous drainage.ndin
re-op
atmen
days)
2
6
2
14
1
E
4
E
E
E
E
3
; CHgen three (25%), and chronic kidney disease in two (17.6%).
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Volume 55, Number 1 Kan et al 57Six patients had ruptured aneurysms (three in free
ruptured and unstable status, three in contained ruptured
but stable vital signs), and five received emergency EVAR
operations. Patient 4, with an associated with type B dis-
secting aneurysm, underwent elective conventional surgery
due to stable hemodynamic status. Fever was present in two
of the five emergency operative cases. Fever was controlled in
most of the patients undergoing elective operations preoper-
atively except patient 5. Urgent operation was commenced
under the impression of impending rupture, although he still
had fever, due to sudden, intractable abdominal pain.
In addition to the typical infectious presentation and the
imaging appearance on CT, all patients had positive blood cul-
ture reports showing 10 Salmonella, one Staphylococcus, and one
Streptococcus spp. One patient received concomitant laparot-
omy for visceral vessel (right hepatic artery, superior mes-
enteric artery, and renal artery) bypass graft surgery. Three
patients subsequently received CT-guided percutaneous
Fig 1. A and B, A computed tomography (CT) scan sh
Salmonella-infected abdominal aortic aneurysm with con
stent graft with femorofemoral bypass surgery. D, Later,
minilaparotomy for open debridement due to persisten
angiography 13 months later showed the osteomyelitis
without any specific symptoms.tube drainage, one of whom also underwent a minilapa- potomy for open debridement due to persistent fever with
pine osteomyelitis (Fig 1, A-D). After 4 weeks of intrave-
ous antibiotics postoperatively, lifelong oral antibiotics
ere maintained, if possible.
There were no hospital deaths and no paraplegia oc-
urred. However, an injury to the kidney occurred in one
atient during dissection of the right renal artery for extra-
natomic bypass surgery, which resulted in nephrectomy
nd end-stage renal failure requiring long-term hemodial-
sis. One patient required prolonged ventilator support for
0 days, and two patients had episodes of acute renal
ailure. The patient who had spine osteomyelitis with per-
istent fever received a further minilaparotomy for open
ebridement, which resolved the fever. However, the os-
eomyelitis image persisted on the follow-up CT angiogra-
hy 13months later, even though the EVAR stent graft was
ntact without any specific symptoms (Fig 1, E and F).
Patient 9 (Table I) died at 8 months postoperatively. The
patient 7, an 81-year-old man, had osteomyelitis and a
d rupture. C,He received an aortouniiliac endovascular
nderwent CT-guided percutaneous drainage and then a
r with spinal osteomyelitis. E and F, A follow-up CT
ersisted, even though the EVAR stent graft was intactowed
taine
he u
t feve
still possible cause was severe hypoglycemia with out-hospital circu-
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stentor reinfection.Allotherpatientswerewell,withnoevidence
of EVAR graft infection, at a mean follow-up of 23.6 months
(range, 2-48months). The psoas abscesses (three of three) were
completely absorbed1 year (Fig 2).
DISCUSSION
Although infected aortic aneurysms are only encoun-
tered in very small subgroups of patients with aortic dis-
eases, their management remains a clinical challenge. To
date, the widely accepted gold standard is to extensively resect
the infected aorta, aggressively debride the periaortic tissues,
and reconstruct the aortic flow using extra-anatomic or ana-
tomic bypass prosthetic grafts.4,7 The biggest advantage of
open surgery is that extensive debridement and excision of
infected aortic tissue is still the optimal way to eradicate the
source of infection; however, even after aggressive debride-
ment, it is difficult to ensure that no microinfected nidus
remains or to guarantee that the new prosthetic grafts will
not be reinfected. Even in the last decade, up to 30% to 40%
in-hospital mortality, depending on the location of the
aneurysm and the severity of systemic inflammation, has
been reported after open surgical management.7
The rapidly burgeoning EVAR technique provides a
less invasive alternative with favorable results in the man-
agement of infected aortic aneurysms on a very selected
Fig 2. Serial computed tomography scans are shown fo
aneurysm and received the endovascular aortic repair, C
prolonged antibiotics treatment. At 1 year later, the psobasis but is not done routinely.10,13 Furthermore, compar- ison with conventional surgeries for treating this disease
eveals that EVAR procedures give at least equivalent 24-
onth actual survival rates and actuarial aneurysm-related
vent-free rates.2 The EVAR strategy may thus be a good
lternative for managing infected aortic aneurysms.
Nevertheless, placing a foreign body in an infected field
eems to go against surgical principles and its acceptability
emains controversial. There is always concern about per-
istent infection after placing a stent graft in an infected
eld. However, because early and prolonged broad-
pectrum antibiotic usage might eliminate the infection
oci, the lack of microbes in initial tissue or blood cultures
nd aggressive adjunct procedures after EVAR have been
roposed as explanations for the success of EVAR treat-
ent of infected aortic aneurysms.13 In addition, because
he endoprosthesis is located within the aorta and is com-
letely soaked with blood and antibiotics within, the anti-
iotics may slowly permeate through the graft into the
urrounding foci to eradicate the infection, acting like a
low-release device.
Our goal in a ruptured aneurysm is to let the EVAR
tent graft seal the ruptured hole first, ensuring patient
urvival, and then use bacteria-specific sensitive antibiotics
o eradicate the macro- and microinfected nidus within the
ody. Our surgical strategy is thus to draw blood for
ultures in every suspected case of infected aortic aneurysm,
ient 6, who had a Salmonella-infected abdominal aortic
ided percutaneous drainage adjunctive procedure, and
cess had completely resolved.r pat
T-gummediately prescribe broad-spectrum antibiotics, and per-
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Volume 55, Number 1 Kan et al 59form EVAR procedures electively if the patient’s vital signs
are stable and fever is controlled. If the patient’s hemody-
namic status is unstable or resuscitated, urgent or emer-
gency EVAR procedures are performed, followed by the
aggressive use of specific intravenous antibiotics according
to culture results for 4 to 6 weeks postoperatively.
In addition, we evaluate these patients by CT angiog-
raphy1 week after the procedure and arrange CT-guided
percutaneous drainage or minimal surgical debridement if
necessary. Patients are also prescribed oral antibiotics for at
least 1 year. As a result of this strategy, all of our patients
have had a satisfactory outcome, without evidence of recur-
rent aortic infection. In the patient with evidence of con-
tinued infection, osteomyelitis was seen on some of his
thoracic vertebra in the CT scan.
Ruptured aneurysm and fever at operation are the two
most significant predictors of persisting infection for
EVAR.13 Free ruptured aneurysm was an emergency con-
dition and needed emergency surgery to save the patient’s
life. In such a situation, the patient inevitably might have
persistent fever. But with aggressive antibiotics therapy, the
infection was controlled eventually. We like to control the
fever preoperatively, if possible, when patients’ hemody-
namics are stable; therefore, five patients received EVAR
after their fever had been controlled by antibiotics. One
patient, however, presented with severe pain with symp-
toms suggestive of impending rupture and underwent
EVAR even when he still had fever. Fortunately, his infec-
tious condition was well controlled. Therefore, using this
EVAR procedure plus an aggressive antibiotic strategy
might be speculated to be effective in this infectious disease.
One of the factors underlying our successful manage-
ment might be that most of our patients were infected with
Salmonella spp. As a result of the availability of over-the-
counter antibiotics and the liberal use of antibiotics in
food-producing animals,14 nontyphoid Salmonella spp
(especially S choleraesuis) account for 50% to 74% of the
pathogens in infected aneurysms in Taiwan.2,3,5 In this
study, this rate amounted to 83%. These Salmonella patho-
gens might be eliminated by the broad-spectrum antibiot-
ics, so if we could delay surgery, combined with preopera-
tive antibiotic usage, for up to 1 week, the results of EVAR
could be impressive.13 One dose of preoperative antibiotic
might also help to eradicate these pathogens in high-risk
patients with free ruptured status who require emergency
EVAR procedures.
Fortunately, we did not identify any pathogens related
to oxacillin-resistance Staphylococcus aureus (ORSA) spp in
our series. ORSA is believed to be an extremely virulent
species that is difficult to control using only antibiotics,
although several successful cases have been reported.7,15,16
Aggressive adjunct procedures after EVAR have been
proposed as one of the explanations for the success of
EVAR treatment of infected aortic aneurysms.13 Our lim-
ited experience showed that most patients with an abscess
adjacent to the psoas muscle can be temporarily treated by
initial percutaneous CT-guided drainage and gradually
controlled by subsequent antibiotics. Even in the patient Oith destructive spinal osteomyelitis, minilaparotomy for
pen debridement immediately controlled the infection
ithout major complications.
The outcome analysis of pathogens for infected aortic
neurysm treatment in our previous review revealed only
almonella infection is a risk factor for aneurysm-related
orbidity and death. No significant statistical difference
as found for Staphylococcus and methicillin-resistant S
ureus.2 In this series, patient 9 (Staphylococcus) recovered
ell after prolonged ventilator support, but died of hypogly-
emia at 8 months. Another unsatisfactory outcome occurred
n patient 12 (Streptococcus), whom we treated using EVAR
lus extra-anatomic visceral vessel bypass with graft and who
eeded long-term hemodialysis. Because of severe adhesive
onditions caused by severe inflammation, the kidney was
njured during tissue dissection. However, both events were
rrelevant to the pathogens and reinfections.
Our study has some limitations. Although we have grad-
ally gained more experience using EVAR to treat infected
atients, the number of patients treated using this strategy in
he three hospitals remains limited. Most of the pathogens
dentified were Salmonella spp, and we had no experience
reating patients with ORSA pathogens. Further studies are
equired to demonstrate the effect of our therapeutic strategy
n patients with aortic infection caused by to other pathogens.
e are thus planning to examine all such patients treated in
aiwan and to report the overall results.
ONCLUSIONS
This small multi-institutional study summarizes our
xperience of treated patients with infected aortic aneu-
ysms by using an EVAR procedure plus an aggressive
ntibiotic strategy. By treating these patients immediately
ith preoperative antibiotics and EVAR stent grafts, fol-
owed by aggressive antibiotic usage and adjunctive proce-
ures, we were able to stabilize these patients and gain
ore time and space in which to administer further treat-
ent. Therefore, this EVAR strategy might be a suitable
lternative to conventional surgery for infected aortic aneu-
ysms. These favorable results may be typical for Salmonella
nfection, which was present in most patients. Further experi-
nce is needed to assess whether this therapeutic strategy
orks equally well in infected aneurysms caused by other
rganisms. Further multi-institutional studies will give more
nformation about this treatment strategy.
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